Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
24.70
-0.22 (-0.88%)
Oct 8, 2026, 10:12 AM EDT - Market open
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $638.26 million as of October 8, 2026. It is the 13,118th most valuable company in the world and the 2,582nd biggest in the United States. Its market cap has increased by 4,395.54% in one year.
Market Cap
638.26M
Enterprise Value
452.41M
1-Year Change
4,395.54%
Global Rank
Country Rank
#2,582 United States
Category
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $638.26M, an increase of 14.25%. That is a compound annual growth rate of 2.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 638.26M | 4,642.61% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 757.01M |
| Wave Life Sciences | 738.93M |
| Verastem | 724.51M |
| Olema Pharmaceuticals | 721.86M |
| Achieve Life Sciences | 721.35M |
| OmniAb | 715.32M |
| 4D Molecular Therapeutics | 713.76M |
| Nuvectis Pharma | 696.92M |